MDxHealth SA (MDXH)
NASDAQ: MDXH · Real-Time Price · USD
3.600
-0.040 (-1.10%)
At close: Dec 5, 2025, 4:00 PM EST
3.670
+0.070 (1.94%)
After-hours: Dec 5, 2025, 5:58 PM EST
MDxHealth Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for MDxHealth stock ranges from a low of $7.00 to a high of $9.00. The average analyst price target of $7.67 forecasts a 113.06% increase in the stock price over the next year.
Price Target: $7.67 (+113.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MDxHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $5 → $7 | Strong Buy | Maintains | $5 → $7 | +94.44% | Nov 13, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $7 → $9 | Strong Buy | Maintains | $7 → $9 | +150.00% | Nov 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | +94.44% | Nov 13, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $6 | Buy | Maintains | $8 → $6 | +66.67% | Nov 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $7 | Buy | Maintains | $6 → $7 | +94.44% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
111.07M
from 90.05M
Increased by 23.34%
Revenue Next Year
136.59M
from 111.07M
Increased by 22.98%
EPS This Year
-0.59
from -1.16
EPS Next Year
-0.31
from -0.59
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 115.6M | 148.4M | ||
| Avg | 111.1M | 136.6M | ||
| Low | 105.8M | 124.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 28.4% | 33.6% | ||
| Avg | 23.3% | 23.0% | ||
| Low | 17.5% | 12.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.36 | -0.21 | |
| Avg | -0.59 | -0.31 | |
| Low | -0.64 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.